Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2009-1-28
pubmed:abstractText
Mutations in genes coding for transducers participating in the RAS/MAPK pathway have been identified as the molecular cause underlying a group of clinically related developmental disorders with cognitive deficits of variable severity. To determine the spectrum of cognitive defects associated with dysregulation of this signal cascade, we studied the profile of cognitive abilities in patients with mutations affecting the PTPN11, SOS1, HRAS, KRAS, BRAF, RAF1, and MEK1 genes and phenotype-genotype correlations. Our findings support the observation that heterogeneity in cognitive abilities can be at least partially ascribed to the individual affected genes and type of mutation involved. While mutations affecting transducers upstream of RAS were less frequently associated with mental retardation, mutations in downstream components of the pathway were generally associated with a more severe cognitive impairment. Among patients with a heterozygous PTPN11 mutation, the T468M substitution was associated with a mean IQ significantly higher compared to that of individuals carrying the N308D change. Our study provides insights on the range of cognitive abilities in patients with gene mutations causing dysregulation of RAS signaling suggesting that the presence and severity of cognitive involvement can be predicted in part by the gene involved.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1552-4833
pubmed:author
pubmed:copyrightInfo
(c) 2009 Wiley-Liss, Inc.
pubmed:issnType
Electronic
pubmed:volume
149A
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
140-6
pubmed:dateRevised
2010-3-2
pubmed:meshHeading
pubmed-meshheading:19133693-Adolescent, pubmed-meshheading:19133693-Adult, pubmed-meshheading:19133693-Child, pubmed-meshheading:19133693-Child, Preschool, pubmed-meshheading:19133693-Cognition Disorders, pubmed-meshheading:19133693-Developmental Disabilities, pubmed-meshheading:19133693-Female, pubmed-meshheading:19133693-Humans, pubmed-meshheading:19133693-Infant, pubmed-meshheading:19133693-MAP Kinase Kinase 1, pubmed-meshheading:19133693-MAP Kinase Signaling System, pubmed-meshheading:19133693-Male, pubmed-meshheading:19133693-Mutation, pubmed-meshheading:19133693-Phenotype, pubmed-meshheading:19133693-Protein Tyrosine Phosphatase, Non-Receptor Type 11, pubmed-meshheading:19133693-Proto-Oncogene Proteins B-raf, pubmed-meshheading:19133693-Proto-Oncogene Proteins c-raf, pubmed-meshheading:19133693-Proto-Oncogene Proteins p21(ras), pubmed-meshheading:19133693-SOS1 Protein, pubmed-meshheading:19133693-Young Adult, pubmed-meshheading:19133693-ras Proteins
pubmed:year
2009
pubmed:articleTitle
Cognitive profile of disorders associated with dysregulation of the RAS/MAPK signaling cascade.
pubmed:affiliation
Pediatric Neurology Unit, Catholic University, Rome, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't